By Spy Uganda Uganda’s plan to inject an additional US$434 million (about Shs1.74 trillion) into Dei BioPharma has come under parliamentary scrutiny, with legislators demanding proof of government shareholding, an independent valuation of the company and an audit of the Shs723.4 billion already committed to the pharmaceutical manufacturing project. The concerns emerged during a plenary…